Morning Briefing
Summaries of health policy coverage from major news organizations
Scientists Close In On Blood Test To Diagnose CTE In The Living
The New York Times: Studies Could Pave Way For Blood Test To Detect C.T.E. In Living Patients
Scientists believe they are one step closer to developing a blood test that could diagnose a degenerative and incurable brain disease often seen in football players, and which causes memory loss, dementia and troubling changes in behavior. The disease, known as C.T.E., or chronic traumatic encephalopathy, is caused by repeated blows to the head, stalking players of contact sports as well as military personnel and victims of domestic violence. (Jacobs, 11/19)
HealthDay: Millions Of Non-Athletic Americans Could Have Undiagnosed CTE
Brain damage linked to contact sports like football and hockey is incredibly rare among non-athletes, but can still occur, a new evidence review says. Fewer than 1% of brains donated from people who never played contact sports had chronic traumatic encephalopathy (CTE), researchers reported Nov. 18 in JAMA Network Open. (Thompson, 11/19)
More news about mental health —
States Newsroom: Psychedelic Mental Healthcare For Veterans Wins Bipartisan Backing
Federal regulators could be on the cusp of approving psychedelic-assisted mental health treatment for veterans, but lawmakers asked tough questions Wednesday of Trump administration officials over whether the Department of Veterans Affairs can meet patients’ needs, and if federal law enforcement and health agencies are on the same page. (Murray, 11/19)
MedPage Today: FDA Approves First Treatment For Neurologic Symptoms Of Type 3 Gaucher Disease
The FDA approved venglustat (Infilbray) tablets as the first treatment for neurologic symptoms of type 3 Gaucher disease in adults and children weighing at least 15 kg, the agency announced Wednesday. Gaucher disease is a rare, inherited lysosomal storage disorder caused by a deficiency of glucocerebrosidase. Without this enzyme, glycosphingolipids build up, mainly in macrophages in the spleen, liver, bone marrow, and lungs. (George, 11/19)
Stat: How Brain Implant Trial Participants Want Researchers To Do Better
So you’ve been diagnosed with ALS — what now? Maybe you join a clinical trial for a brain implant that could help you do things like move your hand or talk to your loved ones. But can you influence the research as a participant? And what happens to the data collected from your brain when the study ends? (Broderick, 11/20)
The New York Times: Marsha Linehan Has Died. She Transformed Treatment For Personality Disorder.
Marsha Linehan, a psychologist who developed a groundbreaking therapy for people struggling with borderline personality disorder and the suicidal thoughts that often come with it — a treatment that, she later revealed, was inspired by her own struggles with the same condition as a young adult — died on Nov. 10 in Seattle. She was 83. Her death from complications of pneumonia, in hospice care, was announced by the Linehan Institute, which she founded to spread information and training about the treatment, dialectical behavior therapy, or D.B.T. (Risen, 11/19)
In other health and wellness news —
Fox News: One Popular Type Of Alcohol Spares Kidneys, While Others Raise Injury Risk
People who regularly drink beer or hard liquor face a significantly higher risk of sudden kidney damage than light drinkers, while wine drinkers do not show the same increased risk, according to a large British study. Researchers at Anglia Ruskin University analyzed health and lifestyle data from 250,791 adult drinkers in the UK Biobank database, tracking them for an average of 14 years. (Quill, 11/19)
Stat: Peptides Go Mainstream As Hims And Noom Enter The Market
Peptides are poised to go mainstream with this week’s launches from telehealth companies Hims & Hers and Noom, both of which announced they will be offering prescriptions for eligible patients. (Todd and Palmer, 11/19)
Fortune: Seed-Oil-Free Foods Are Now A $1 Billion Business. Scientists Say The Health Claims Don’t Hold Up
Walk down the snack aisle of almost any grocery store and you’ll find a growing number of packages labeled seed-oil-free. Americans bought more than $1 billion worth of seed-oil-free food products over the past year, according to NielsenIQ data. (Lake, 11/20)